247 related articles for article (PubMed ID: 20337588)
1. In silico techniques for the identification of bioisosteric replacements for drug design.
Devereux M; Popelier PL
Curr Top Med Chem; 2010; 10(6):657-68. PubMed ID: 20337588
[TBL] [Abstract][Full Text] [Related]
2. In silico identification of bioisosteric functional groups.
Ertl P
Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
[TBL] [Abstract][Full Text] [Related]
3. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
Jónsdóttir SO; Jørgensen FS; Brunak S
Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
[TBL] [Abstract][Full Text] [Related]
4. Computational approaches for fragment-based and de novo design.
Loving K; Alberts I; Sherman W
Curr Top Med Chem; 2010; 10(1):14-32. PubMed ID: 19929832
[TBL] [Abstract][Full Text] [Related]
5. In silico prediction of ADMET properties: how far have we come?
Dearden JC
Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):635-9. PubMed ID: 17916052
[TBL] [Abstract][Full Text] [Related]
6. Random molecular fragment methods in computational medicinal chemistry.
Lounkine E; Batista J; Bajorath J
Curr Med Chem; 2008; 15(21):2108-21. PubMed ID: 18781938
[TBL] [Abstract][Full Text] [Related]
7. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
Bonnet P
Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
[TBL] [Abstract][Full Text] [Related]
8. Large-scale exploration of bioisosteric replacements on the basis of matched molecular pairs.
Wassermann AM; Bajorath J
Future Med Chem; 2011 Mar; 3(4):425-36. PubMed ID: 21452979
[TBL] [Abstract][Full Text] [Related]
9. The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization.
Bruno A; Costantino G; Sartori L; Radi M
Curr Med Chem; 2019; 26(21):3838-3873. PubMed ID: 29110597
[TBL] [Abstract][Full Text] [Related]
10. MB-Isoster: A software for bioisosterism simulation.
Elias TC; de Oliveira HCB; da Silveira NJF
J Comput Chem; 2018 Nov; 39(29):2481-2487. PubMed ID: 30318630
[TBL] [Abstract][Full Text] [Related]
11. Parallel worlds of public and commercial bioactive chemistry data.
Lipinski CA; Litterman NK; Southan C; Williams AJ; Clark AM; Ekins S
J Med Chem; 2015 Mar; 58(5):2068-76. PubMed ID: 25415348
[TBL] [Abstract][Full Text] [Related]
12. Database of bioactive ring systems with calculated properties and its use in bioisosteric design and scaffold hopping.
Ertl P
Bioorg Med Chem; 2012 Sep; 20(18):5436-42. PubMed ID: 22436390
[TBL] [Abstract][Full Text] [Related]
13. Computational Chemistry in the Pharmaceutical Industry: From Childhood to Adolescence.
Hillisch A; Heinrich N; Wild H
ChemMedChem; 2015 Dec; 10(12):1958-62. PubMed ID: 26358802
[TBL] [Abstract][Full Text] [Related]
14. Bioisosteric similarity of molecules based on structural alignment and observed chemical replacements in drugs.
Krier M; Hutter MC
J Chem Inf Model; 2009 May; 49(5):1280-97. PubMed ID: 19402687
[TBL] [Abstract][Full Text] [Related]
15. Data structures and computational tools for the extraction of SAR information from large compound sets.
Wawer M; Lounkine E; Wassermann AM; Bajorath J
Drug Discov Today; 2010 Aug; 15(15-16):630-9. PubMed ID: 20547243
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening: are we there yet?
Jalaie M; Shanmugasundaram V
Mini Rev Med Chem; 2006 Oct; 6(10):1159-67. PubMed ID: 17073716
[TBL] [Abstract][Full Text] [Related]
17. BioisoIdentifier: an online free tool to investigate local structural replacements from PDB.
Zhang T; Sun S; Wang R; Li T; Gan B; Zhang Y
J Cheminform; 2024 Jan; 16(1):7. PubMed ID: 38218937
[TBL] [Abstract][Full Text] [Related]
18. Fragment informatics and computational fragment-based drug design: an overview and update.
Sheng C; Zhang W
Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
[TBL] [Abstract][Full Text] [Related]
19. Computational techniques for diversity analysis and compound classification.
Kitchen DB; Stahura FL; Bajorath J
Mini Rev Med Chem; 2004 Dec; 4(10):1029-39. PubMed ID: 15579111
[TBL] [Abstract][Full Text] [Related]
20. MolOpt: A Web Server for Drug Design using Bioisosteric Transformation.
Shan J; Ji C
Curr Comput Aided Drug Des; 2020; 16(4):460-466. PubMed ID: 31272357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
